Investigating the epidemiology of medication errors and error-related adverse drug events (ADEs) in primary care, ambulatory care and home settings: a systematic review protocol

BMJ Open

Volumn 6, Issue 8, 2016, Pages

  Assiri, Ghadah Asaad ^a,b   Grant, Liz ^a   Aljadhey, Hisham ^b   Sheikh, Aziz ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE DRUG REACTION; AMBULATORY CARE; HOME CARE; HUMAN; MEDICATION ERROR; META ANALYSIS; METHODOLOGY; PRIMARY HEALTH CARE; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; AMBULATORY CARE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOME CARE SERVICES; HUMANS; MEDICATION ERRORS; PRIMARY HEALTH CARE; RESEARCH DESIGN;

EID: 85038392731     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/BMJOPEN-2015-010675     Document Type: Review

References (24)

1. Mark SM LJ, Geller S, Weber RJ. Chapter 5. Principles and practices of medication safety. In: DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: a pathophysiologic approach: New York, NY: McGraw-Hill, 2011 (Accessed Oct 10, 2015).
2. What is a Medication Error? National Coordinating Council for Medication Error Reporting and Prevention (cited 16 October 2015). http://www.nccmerp.org/about-medication-errors
3. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
4. Sorensen L, Stokes JA, Purdie DM, et al. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther 2006;31:485-91.
5. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832-40.
6. Krähenbühl-Melcher A, Schlienger R, Lampert M, et al. Drug-related problems in hospitals: a review of the recent literature. Drug Saf 2007;30:379-407.
7. Kongkaew C, Hann M, Mandal J, et al. Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy 2013;33:827-37.
8. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001;41:192-9.
9. Kozer E. Medication errors in children. Paediatr Drugs 2009;11:52-4.
10. Zakharov S, Tomas N, Pelclova D. Medication errors-an enduring problem for children and elderly patients. Ups J Med Sci 2012;117:309-17.
11. Machado JE, Moncada JC, Mesa G. [Prescription patterns for antilipidemic drugs in a group of Colombian patients]. Rev Panam Salud Publica 2008;23:179-87.
12. Olaniyan JO, Ghaleb M, Dhillon S, et al. Safety of medication use in primary care. Int J Pharm Pract 2015;23:3-20.
13. Panesar SS, deSilva D, Carson-Stevens A, et al. How safe is primary care? A systematic review. BMJ Qual Saf 2016;25:544-53.
14. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington DC: National Academies Press (US) Copyright 2000 by the National Academy of Sciences. All rights reserved, 2000.
15. Sheikh A, Panesar SS, Larizgoitia I, et al. Safer primary care for all: a global imperative. Lancet Glob Health 2013;1:e182-3.
16. Cresswell KM, Panesar SS, Salvilla SA, et al. Global research priorities to better understand the burden of iatrogenic harm in primary care: an international Delphi exercise. PLoS Med 2013;10: e1001554.
17. Emanuel L, Berwick D, Conway J, et al. What exactly is patient safety? In: Henriksen K, Battles JB, Keyes MA, et al, eds. Advances in patient safety. New Directions and Alternative Approaches, 2008.
18. Critical Appraisal Skills Programme checklist for cohort studies (cited 10 October 2015). http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_Cohort_Appraisal_Checklist_14oct10.pdfwebcite
19. Joanna Briggs Institute. Checklist for critical appraisal of descriptive studies (cited 16 October 2015). http://joannabriggs.org/assets/docs/jbc/operations/criticalAppraisalForms/JBC_Form_CritAp_DescCase. pdf
20. Borenstein M, Hedges LV, Higgins JPT, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010;1:97-111.
21. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
22. Beller EM, Glasziou PP, Altman DG, et al, PRISMA for Abstracts Group. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med 2013;10:e1001419.
23. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
24. What are over-the-counter (OTC) drugs and how are they approved? U.S. Food and Drug Administration (cited 19 October 2015). http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194951.htm